Dr. Peter Watson
Dr. Peter Watson is Director of the Biobanking and Biospecimen Research Services program at BC Cancer, an agency of the Provincial Health Services Authority (PHSA) in British Columbia. He also holds appointments as Senior Scientist and as Professor of Pathology, University of British Columbia, and as adjunct faculty at the University of Victoria.
He completed his medical training at the University of Cambridge and St Thomas's Hospital London, UK in 1983 and specialist training in Anatomic Pathology at the University of Manitoba in 1988. After fellowship training he established a career as a clinician scientist in 1993 at the University of Manitoba, and since 2005 has been at BC Cancer.
He currently combines a clinical practice as a breast pathologist with research interests in the molecular pathology of breast and ovarian cancer, and in biospecimen and biobanking resources. His research program focuses on biomarkers of breast tumour progression and response to therapies. This work has included the discovery, validation, elucidation of the mechanism of action, and exploration of the therapeutic potential of the S100A7 gene in breast cancer. This research has led to publication of over 175 scientific research papers.
He has also led provincial and national biobanking initiatives to advance translational cancer research. In addition, Dr. Watson serves as co-lead of the Canadian Tissue Repository Network (CTRNet) and he is currently the director of the University of British Columbia, Department of Pathology Office of Biobank Education and Research, serves on the executive of the Marble Arch International Working Group for Biobanking, and is Deputy Editor for the journal Biopreservation and Biobanking.